GENE ONLINE|News &
Opinion
Blog

Antibody-Drug Conjugate
US BIO 2024 KriSan Biotech
KriSan Biotech Expands ADC CrDMO Services to Global Biotech Companies
2024-06-04
Editors' Picks Healthcare Industrybiotechbiopharma
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Trending JPMJP Morgan 2024
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
Trending Antibody-Drug ConjugateRocheSanofiBristol Myers SquibbSeagenBioNTech
Reviewing the Market Trends in the Antibody-Drug Conjugate Development: A Focus on Roche, Sanofi, BMS, Seagen, and BioNTech
2024-01-05
Partnerships ADC
SystImmune Partners with Bristol-Myers Squibb to Develop and Commercialize Bispecific ADC Globally
2023-12-13
Asia-Pacific Cancer
Daiichi Sankyo Advances Care Standards with Groundbreaking Cancer Treatment
2023-10-20
Special ASCOOncology
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Partnerships Antibody-Drug ConjugateOncology
Pyramid Biosciences Bets $1B on Oncology Drug
2023-04-17
M&A PfizerSeagen
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Asia-Pacific Antibody-Drug Conjugate
First Made-in-Singapore Antibody-Drug Conjugate Approved to Enter Clinical Trials
2023-01-09
Asia-Pacific Antibody-Drug Conjugate
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
Trials & Approvals Ovarian Cancer
ImmunoGen Wins FDA Accelerated Approval For Ovarian Cancer Drug
2022-11-16
Licensing Antibody-Drug Conjugate
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Trials & Approvals China
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
Trials & Approvals Breast Cancer
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
1 2
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top